Multiple ascending dose study of seraprevir potassium, a nonstructural protein 3/4A replication complex inhibitor, in patients infected with hepatitis C virus

Authors
Category Primary study
JournalJournal of Hepatology
Year 2017
This article has no abstract
Epistemonikos ID: c0762483f1a51687e8f6a3e898e11c5de97bcfd7
First added on: Feb 09, 2025